Prosecution Insights
Prosecution Insights
45 pending office actions • 23 clients • 43 examiners • 30 art units • 0 of 45 (0%) have an AI response strategy ready • 77 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 43 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 43 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 27 (60%) |
| §102 only | 7 (16%) |
| §112 only | 5 (11%) |
| No statute on record | 6 (13%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CORNET, JEAN P | 2 | 42.0% | +47.8% |
| WOODWARD, ANA LUCRECIA | 2 | 73.1% | +16.8% |
| STEPHENSON, DANIEL P | 1 | 86.6% | -25.9% |
| TRAN, ERIC | 1 | 68.7% | +24.7% |
| ABDALHAMEED, MANAHIL MIRGHANI ALI | 1 | 50.4% | +41.3% |
| ANDERSON, JAMES D | 1 | 55.1% | +19.2% |
| CRAIGO, WILLIAM A | 1 | 49.3% | +38.7% |
| AWORUNSE, OLUWABUSAYO ADEBANJO | 1 | 0.0% | +0.0% |
| MCDONOUGH, JAMES E | 1 | 71.4% | +11.1% |
| SHTERENGARTS, SAMANTHA L | 1 | 79.4% | +7.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19265750 | METHOD FOR CEMENTATION IN CARBONATE ROCKS UNDER SEVERE CIRCULATION LOSS CONDITIONS | STEPHENSON, DANIEL P | 35d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18696645 | AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL | AWORUNSE, OLUWABUSAYO ADEBANJO | 146d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18544954 | ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | CORNET, JEAN P | 92d overdue |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | TRAN, ERIC | 44d overdue |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | ANDERSON, JAMES D | 44d overdue |
| 18865881 | TRYPTAMINE DERIVATIVES | ABDALHAMEED, MANAHIL MIRGHANI ALI | 35d overdue |
| 17768045 | WEATHERING-RESISTANT STYRENE COPOLYMER MOLDING COMPOSITIONS WITH REDUCED MOLD DEPOSIT FORMATION FOR HIGH GLOSS APPLICATIONS | WOODWARD, ANA LUCRECIA | 29d overdue |
| 17766877 | STYRENE COPOLYMER MOLDING COMPOSITIONS WITH REDUCED MOLD DEPOSIT FORMATION FOR HIGH GLOSS APPLICATIONS | WOODWARD, ANA LUCRECIA | 29d overdue |
| 18665039 | PEPTIDE SLOW-RELEASE FORMULATIONS | CRAIGO, WILLIAM A | 9d overdue |
| 18469884 | CATALYST FORMULATION FOR DIRECT CONVERSION OF MICROALGAE IN GROWTH MEDIUM TO BIOFUELS | MCDONOUGH, JAMES E | 1d overdue |
| Art Unit | Apps |
|---|---|
| 3791 | 4 |
| 1628 | 3 |
| 1763 | 3 |
| 1691 | 3 |
| 1629 | 2 |
| 1622 | 2 |
| 1623 | 2 |
| 1656 | 2 |
| 1655 | 2 |
| 1765 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19265750 | METHOD FOR CEMENTATION IN CARBONATE ROCKS UNDER SEVERE CIRCULATION LOSS CONDITIONS | Petroleo Brasileiro S.A. - Petrobras | STEPHENSON, DANIEL P | 3676 | §112 | Non-Final OA | 35d overdue | Pending | Jul 10, 2025 |
| 19189953 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | TRAN, ERIC | 1629 | §103 | Final Rejection | 44d overdue | Pending | Apr 25, 2025 |
| 18865881 | TRYPTAMINE DERIVATIVES | Caamtech, Inc. | ABDALHAMEED, MANAHIL MIRGHANI ALI | 1622 | §103 | Non-Final OA | 35d overdue | Pending | Nov 14, 2024 |
| 18858080 | CRYSTALLINE QUATERNARY SALTS OF 4-SUBSTITUTED TRYPTAMINES | Caamtech, Inc. | ANDERSON, JAMES D | 1629 | §102 | Non-Final OA | 44d overdue | Pending | Oct 18, 2024 |
| 18665039 | PEPTIDE SLOW-RELEASE FORMULATIONS | Camurus AB | CRAIGO, WILLIAM A | 1615 | Other | Non-Final OA | 9d overdue | Pending | May 15, 2024 |
| 18696645 | AUTONOMOUS ROBOT PLATFORM FOR PEST IDENTIFICATION AND CONTROL | Tecsoil Automacao E Sistemas S.A | AWORUNSE, OLUWABUSAYO ADEBANJO | 3662 | §103 | Non-Final OA | 146d overdue | Pending | Mar 28, 2024 |
| 18544954 | ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | Caamtech, Inc. | CORNET, JEAN P | 1628 | §103 | Non-Final OA | 92d overdue | Pending | Dec 19, 2023 |
| 18469884 | CATALYST FORMULATION FOR DIRECT CONVERSION OF MICROALGAE IN GROWTH MEDIUM TO BIOFUELS | Socar Turkey Arastirma Gelistirme Ve Inovasyon A.S. | MCDONOUGH, JAMES E | 1734 | §103 | Non-Final OA | 1d overdue | Pending | Sep 19, 2023 |
| 18279293 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | SHTERENGARTS, SAMANTHA L | 1623 | §102 | Non-Final OA | 48d | Pending | Aug 29, 2023 |
| 18279290 | INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Mindset Pharma Inc. | AULAKH, CHARANJIT | 1621 | §102 | Non-Final OA | 5d | Pending | Aug 29, 2023 |
| 18360612 | PREPARING AND USE OF GLU-PLASMINOGEN FROM BLOOD FRACTIONS | Previpharma Consulting GmbH | XU, QING | 1656 | Other | Non-Final OA | 9d | Pending | Jul 27, 2023 |
| 18354117 | REACTOR WITH PLATE-SHAPED CATALYTIC MEMBRANE FOR DIRECT CONVERSION OF MICROALGAE INTO BIOFUELS | Socar Turkey Arastirma Gelistirme Ve Inovasyon Anonim Sirketi | MUTREJA, JYOTI NAGPAUL | 1798 | §103 | Non-Final OA | 9d | Pending | Jul 18, 2023 |
| 18352677 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | Caamtech, Inc. | SPAINE, ROBERT FRANKLIN | 1655 | §102 | Non-Final OA | 441d overdue | Pending | Jul 14, 2023 |
| 18257766 | PROCESS FOR PRODUCING A THERMOPLASTIC POLYMER-CONTAINING FIBER-REINFORCED COMPOSITE MATERIAL | Ineos Styrolution Group GmbH | DONAHUE, OLGA LUCIA | 1763 | §103 | Non-Final OA | 23d overdue | Pending | Jun 15, 2023 |
| 18257639 | AMANITA MUSCARIA COMPOUNDS | Caamtech, Inc. | HOFFMAN, SUSAN COE | 1655 | §102 | Non-Final OA | 32d overdue | Pending | Jun 15, 2023 |
| 18265286 | 3-CYCLIC AMINE-INDOLE DERIVATIVES AS SEROTONERGIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Mindset Pharma Inc. | LEE, CHIHYI NMN | 1628 | §103 | Non-Final OA | 26d overdue | Pending | Jun 05, 2023 |
| 18249848 | NANOFILTRATION ASSISTED METHODS OF CHEMICAL SYNTHESIS | BACHEM AG | REYNOLDS, FRED H | 1658 | Other | Non-Final OA | 43d | Pending | Apr 20, 2023 |
| 18249479 | METHOD FOR DEPOLYMERIZING POLYMER MASSES WHILE DEGRADING ORGANIC HALOGEN COMPOUNDS | Ineos Styrolution Group GmbH | FADHEL, ALI Z | 1772 | §103 | Non-Final OA | 33d | Pending | Apr 18, 2023 |
| 18299857 | STATIC MAGNETIC FIELD GENERATOR FOR TREATMENT OF CANCER | BRAIN & BEYONDS CO., LTD. | LANDEEN, BROGAN RANE | 3791 | §103 | Non-Final OA | 2d overdue | Pending | Apr 13, 2023 |
| 18245053 | USE OF ACTIVE SUBSTANCES WITH ANTIVIRAL, ANTI MALARIAL, AND/OR MUCOLYTIC PROPERTIES IN THE TREATMENT OF VIRAL LUNG DISEASES INCLUDING COVID-19 BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Istanbul Universitesi Rektolugu | HAGHIGHATIAN, MINA | 1616 | §103 | Final Rejection | — | Pending | Mar 13, 2023 |
| 18041642 | USE OF A HEPARIN COMPOSITION IN THE TREATMENT OF VIRAL LUNG DISEASES, ACUTE AND/OR CHRONIC LUNG DISEASES BY SOFT MIST INHALER OR VIBRATION MESH TECHNOLOGY NEBULIZER THROUGH INHALATION ROUTE | Istanbul Universitesi Rektorlugu | SHIAO, YIH-HORNG | 1691 | §103 | Non-Final OA | 27d | Pending | Feb 14, 2023 |
| 18105460 | CONJUGATES COMPRISING REVERSIBLE LINKERS AND USES THEREOF | Ascendis Pharma A/S | JOHNSON, CHRISTOPHER LINDSAY | 1691 | — | Non-Final OA | 34d | Pending | Feb 03, 2023 |
| 18003212 | A PERFUSION BALLOON WITH AN EXPANDABLE INTERNAL LUMEN | Polimed Research Sp. Z O.O. | GONZALEZ, LEI NMN | 3783 | §103 | Non-Final OA | 110d overdue | Pending | Dec 23, 2022 |
| 17923314 | HYDROGEL IRRADIATION | Ascendis Pharma A/S | MEJIAS, SAMANTHA LEE | 1618 | §103 | Non-Final OA | 38d overdue | Pending | Nov 04, 2022 |
| 18051678 | BIO-BASED FURANIC DI(METH)ACRYLATES AS REACTIVE DILUENTS FOR UV CURABLE COATINGS | Ndsu Research Foundation | EGWIM, KELECHI CHIDI | 1762 | §102 | Non-Final OA | 4d overdue | Pending | Nov 01, 2022 |
| 17916199 | NANOPARTICLE PROVISION MEDIUM FOR THERMOTHERAPY AND THERMOTHERAPY SYSTEM USING SAME | BRAIN & BEYONDS CO., LTD. | COX, THADDEUS B | 3791 | §112 | Final Rejection | 23d | Pending | Sep 30, 2022 |
| 17914206 | ASA POLYMER COMPOSITION WITH OPTIMISED UV STABILITY AND GOOD TOUGHNESS-STIFFNESS BALANCE | Ineos Styrolution Group GmbH | CAI, WENWEN | 1763 | §103 | Final Rejection | 33d | Pending | Sep 23, 2022 |
| 17802360 | APPARATUS AND SYSTEM FOR GENERATING ALTERNATING MAGNETIC FIELD FOR DISEASE TREATMENT | BRAIN & BEYONDS CO., LTD. | DORNA, CARRIE R | 3791 | §112 | Final Rejection | 6d | Pending | Aug 25, 2022 |
| 17904419 | DRG-MDM2-2 FOR USE AS A NOVEL MOUSE DOUBLE MINUTE 2 (MDM2) INHIBITOR | Istanbul Teknik Universitesi | VALLE, ERNESTO | 1623 | §103 | Non-Final OA | 19d | Pending | Aug 17, 2022 |
| 17759974 | METHOD FOR INTRAOPERATIVELY OR POSTOPERATIVELY DETECTING IDH1 AND IDH2 GENE MUTATIONS IN GLIOMA TUMORS AND PRIMERS USED IN THIS METHOD | BAHCESEHIR UNIVERSITESI | MYERS, CARLA J | 1682 | §102 | Non-Final OA | 187d overdue | Pending | Aug 02, 2022 |
| 17747557 | MEASLES VIRUS ENCODING A TUMOR ANTIGEN | Ruprecht-Karls-Universitat Heidelberg | NOBLE, MARCIA STEPHENS | 1632 | §112 | Final Rejection | 44d overdue | Pending | May 18, 2022 |
| 17769005 | BLACK STYRENE COPOLYMER COMPOSITIONS FOR HIGH GLOSS EXTERIOR APPLICATIONS | Ineos Styrolution Group GmbH | PAK, HANNAH J | 1764 | §103 | Final Rejection | 23d | Pending | Apr 14, 2022 |
| 17768045 | WEATHERING-RESISTANT STYRENE COPOLYMER MOLDING COMPOSITIONS WITH REDUCED MOLD DEPOSIT FORMATION FOR HIGH GLOSS APPLICATIONS | Ineos Styrolution Group GmbH | WOODWARD, ANA LUCRECIA | 1765 | Other | Non-Final OA | 29d overdue | Pending | Apr 11, 2022 |
| 17766877 | STYRENE COPOLYMER MOLDING COMPOSITIONS WITH REDUCED MOLD DEPOSIT FORMATION FOR HIGH GLOSS APPLICATIONS | Ineos Styrolution Group GmbH | WOODWARD, ANA LUCRECIA | 1765 | §103 | Non-Final OA | 29d overdue | Pending | Apr 06, 2022 |
| 17627488 | IMMOBILIZED ENZYME COMPOSITIONS FOR THE PRODUCTION OF HEXOSES | BONUMOSE, INC. | SPANGLER, JOSEPH RANKIN | 1656 | §103 | Final Rejection | 8d overdue | Pending | Jan 14, 2022 |
| 17624863 | STABILIZER COMPOSITION FOR SILYL-MODIFIED POLYMER SEALANTS | Omya International AG | NERANGIS, VICKEY M | 1763 | §103 | Final Rejection | 73d overdue | Pending | Jan 05, 2022 |
| 17596832 | CONJUGATES OF AN ELECTRON-DONATING NITROGEN OR TERTIARY AMINE COMPRISING COMPOUNDS | Ascendis Pharma A/S | ELENISTE, PIERRE PAUL | 1622 | §103 | Non-Final OA | 1d overdue | Pending | Dec 20, 2021 |
| 17612326 | BODY TEMPERATURE DIAGNOSTICS | Vivosensmedical GmbH | TU, AURELIE H | 3791 | §103 | Non-Final OA | 29d | Pending | Nov 18, 2021 |
| 17495069 | ALKYL QUATERNARY AMMONIUM TRYPTAMINES AND THEIR THERAPEUTIC USES | Caamtech, Inc. | CORNET, JEAN P | 1628 | Other | Non-Final OA | 54d | Pending | Oct 06, 2021 |
| 17387883 | PSILOCIN DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS | Mindset Pharma Inc. | MCDOWELL, BRIAN E | 1624 | §112 | Non-Final OA | 89d overdue | Pending | Jul 28, 2021 |
| 17422962 | PLASMINOGEN FOR TREATING AND PREVENTING MICROTHROMBOSIS | Previpharma Consulting GmbH | MOSS, NATALIE M | 1653 | §103 | Final Rejection | 33d | Pending | Jul 14, 2021 |
| 17312249 | A METHOD TO DETERMINE AGENTS FOR PERSONALIZED USE | Henry Johannes Greten | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §103 | Non-Final OA | — | Pending | Jun 09, 2021 |
| 17186762 | SYSTEMS AND METHODS FOR CARBON DIOXIDE ENHANCED DELIVERY OF TOPICAL SUBSTANCES | Cryoconcepts LP | SMITH, PETER DANIEL | 3781 | §103 | Non-Final OA | 46d overdue | Pending | Feb 26, 2021 |
| 16936769 | COMPOSITIONS CONTAINING TOAD SECRETION COMPOUNDS | Caamtech LLC | LEE, ANDREW P | 1691 | §103 | Final Rejection | 42d overdue | Pending | Jul 23, 2020 |
| 16456773 | RNA VIRUSES EXPRESSING IL-12 FOR IMMUNOVIROTHERAPY | Ruprecht-Karls Universitaet | HILL, KEVIN KAI | 1638 | §103 | Non-Final OA | 98d overdue | Pending | Jun 28, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial